Literature DB >> 9453523

Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope.

M Vanderheyden1, M Goethals, P Nellens, E Andries, P Brugada.   

Abstract

Neurocardiogenic dysfunction is believed to result from activation of ventricular mechanoreceptors. To asses other humoral and circulatory mechanisms activated during vasovagal syncope, epinephrine, norepinephrine, renin, and aldosterone levels were measured during head-up tilt testing. Twenty-three patients referred because of vasovagal syncope underwent passive head-up tilt testing (80 degrees). Blood samples were taken at baseline, after 30 minutes of supine rest and at syncope. Five patients (four men, one woman; mean age 46 +/- 27 years) had cardioinhibitory syncope. Seven patients (five men, two women; mean age 40 +/- 12 years) had vasodepressor syncope. Eleven patients (eight men, three women; mean age 55 +/- 21 years) had negative results of head-up tilt tests. Among patients with cardioinhibitory syncope, norepinephrine concentration rose significantly from baseline to syncope (0.44 +/- 0.12 ng/ml versus 1.14 +/- 0.72 ng/ml; p < 0.05), whereas no significant change was observed in epinephrine (0.08 +/- 0.03 ng/ml versus 2.74 +/- 2.85 ng/ml; p = not significant [NS]), renin (5.68 +/- 3.03 pg/ml versus 19.58 +/- 11.47 pg/ml; p = NS), or aldosterone concentration (66.60 +/- 16.10 ng/ml versus 109.00 +/- 44.70 ng/ml; p = NS). Patients with vasodepressor syncope had a significant rise in renin (9.03 +/- 4.56 pg/ml versus 52.53 +/- 41.63 pg/ml; p < 0.05) and aldosterone concentration (95.43 +/- 103.03 ng/ml versus 249.57 +/- 191.54 ng/ml; p < 0.05), whereas no change in level of epinephrine (0.12 +/- 0.12 ng/ml versus 0.28 +/- 0.33 ng/ml; p = NS) or norepinephrine (0.60 +/- 0.26 ng/ml versus 0.86 +/- 0.53 ng/ml; p = NS) was detected. Among patients with negative results of tilt tests, levels of renin (7.94 +/- 7.19 pg/ml versus 27.71 +/- 18.50 pg/ml; p < 0.01) and aldosterone (64.64 +/- 28.33 ng/ml versus 160.91 +/- 79.58 ng/ml; p < 0.01) rose significantly, whereas no change was seen in epinephrine (0.12 +/- 0.14 ng/ml versus 0.23 +/- 0.31; p = NS) or norepinephrine concentration (0.54 +/- 0.21 ng/ml versus 0.82 +/- 0.52; p = NS). Patients with cardioinhibitory syncope were characterized by a rise in norepinephrine level and blunted activation of the renin-angiotensin-aldosterone axis at syncope. Unlike patients with cardioinhibitory syncope, the renin-angiotensin-aldosterone axis is activated in patients with vasodepressor syncope and patients with a negative result of head-up tilt test without a statistically significant increase in catecholamine levels. Patients with cardioinhibitory syncope have higher epinephrine levels at syncope compared with patients with a negative result of head-up tilt test and patients with vasodepressor syncope.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453523     DOI: 10.1016/s0002-8703(98)70344-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  Cerebral blood flow during vasovagal syncope induced by active standing or head up tilt.

Authors:  R Y Sung; Z D Du; C W Yu; M C Yam; T F Fok
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.

Authors:  Ashley L Wagoner; Hossam A Shaltout; John E Fortunato; Debra I Diz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

3.  Orthostatic Changes in Hemodynamics and Cardiovascular Biomarkers in Dysautonomic Patients.

Authors:  David Nilsson; Richard Sutton; Widet Tas; Philippe Burri; Olle Melander; Artur Fedorowski
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 4.  Neurohormones in the Pathophysiology of Vasovagal Syncope in Adults.

Authors:  David G Benditt; J Gert van Dijk; Darshan Krishnappa; Wayne O Adkisson; Scott Sakaguchi
Journal:  Front Cardiovasc Med       Date:  2020-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.